XXEC Inc’s Microbot Medical MBOT Stock Holding History

XXEC Inc’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-92,628	Closed	-$788K	–	28
2021 Q1	$788K	Hold	92,628	–	–	0.55%	30
2020 Q4	$638K	Sell	92,628 -3,182	-3%	-$23.9K	0.5%	28
2020 Q3	$761K	Buy	+95,810	New	+$675K	0.73%	24

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

XXEC Inc's MBOT Position: Q2 2021 in Review

XXEC Inc sold out of Microbot Medical (MBOT) in Q2 2021, closing a stake of 92,628 shares — an estimated $788K sold.

XXEC Inc first reported a position in MBOT in Q3 2020 and held it in 3 quarters. The position peaked at $788K in Q1 2021. 29 funds tracked by Wall St. Rank hold MBOT as of Q2 2021.

XXEC Inc reported no remaining Microbot Medical position as of Q2 2021 after selling out during the quarter.
XXEC Inc sold 92,628 Microbot Medical shares in Q2 2021, an estimated $788K.
XXEC Inc first reported a position in Microbot Medical in Q3 2020 and held it in 3 quarters.
XXEC Inc's Microbot Medical position peaked at $788K in Q1 2021.
29 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2021.

Based on XXEC Inc's 13F filing for Q2 2021, filed 13 Aug 2021.